Polymedco, LLC
  1. Companies
  2. Polymedco, LLC
  3. Products
  4. PATHFAST - Analyzer for Cardiac ...

PATHFAST -Ā Analyzer for Cardiac Biomarker Testing in Emergency Departments

SHARE
The PATHFAST Analyzer is designed to enhance cardiac care in emergency department settings by providing high-sensitivity cardiac troponin (hs-cTn) and NT-proBNP testing capabilities. This compact, benchtop device delivers rapid, lab-quality results within 17 minutes from whole blood samples, utilizing chemiluminescence and MagtrationĀ® technology. The system's flexibility allows simultaneous processing of up to six tests, supporting efficient decision-making for patients with suspected acute coronary syndrome and other cardiac conditions. By offering both hs-cTnI-II and NT-proBNP tests on a single platform, the PATHFAST Analyzer supports rapid risk stratification and admission decisions, optimizing emergency department performance. Its user-friendly operation contributes to reducing the length of patient stays and improving overall patient satisfaction. The PATHFAST Analyzer positions itself as a vital tool in modern emergency rooms, working collaboratively with healthcare professionals to deliver precise, reliable results that meet laboratory standards at the point of care.
Most popular related searches

Laboratory excellence, propelling ED performance

The PATHFAST Analyzer accelerates urgent cardiac care decisions in the Emergency Department (ED) with reliable, lab-quality testing at the point of care.

PATHFAST meets ED goals of accuracy, efficiency & flexibility

Results available in under 17 minutes

Flexibility to run up to 6 tests at once

Space-saving benchtop design for the ED or STAT lab

User-friendly operation

Eliminating preanalytical delays associated with core-laboratory testing has been shown to:

Accelerate care decisions by
40 minutes1

Reduce length of stay by
34 minutes1

The wait is over: The only hs-cTn at the point of care is now available

PATHFAST hs-cTnI-II

Finally, EDs can access an optimal solution to accelerate the assessment and disposition of patients with suspected acute coronary syndrome (ACS).

High-sensitivity cardiac troponin is the preferred assay to be used as an aid in the diagnosis of acute myocardial infarction (AMI)

Lab-quality results

  • 6% CV at the 99th percentile cutoff of 29 ng/L2
  • 4.1 ng/L limit of quantitation (LoQ, I.e. functional sensitivity)2

When and where you need them

  • Results in 17 minutes within care pathway
  • Run up to 6 tests at once

Optimizing ED performance

  • Proven performance in 0/1, 0/2, and 0/3 h accelerated diagnostic protocols3–5

Access to quicker test results can help clinicians identify urgent cardiac concerns sooner, reduce length of stay, and improve patient satisfaction.

Discover more resources

Visit the online resource center for additional education and support materials.